Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 384

Contrary Capital boots up fund

The fund, which has already made its first investments, will offer between $50,000 and $200,000 to both spinouts and student startups.

Sep 22, 2017

ZhongAn zips in to close $1.5bn IPO

SoftBank bought $500m of shares as online insurance platform ZhongAn priced the largest ever fintech IPO in Hong Kong, giving exits to Ping An, Tencent and Ant Financial.

Sep 22, 2017

Weiying finds Maoyan merger just the ticket

Corporate-backed online ticketing service Weiying is set to merge several of its assets with peer Maoyan, which is majority owned by Enlight Media.

Sep 22, 2017

YH Global signs for $182m delivery

Shenzhen Grandland Group has taken part in a series A round for supply chain services provider YH Global, which operates logistics centres in more than 50 Chinese cities.

Sep 22, 2017

BMW grasps DSP Concepts in $10m round

BMW i Ventures has led a series A round for DSP Concepts, the creator of software that helps developers add voice control to their products.

Sep 22, 2017

Mahindra senses Cloudleaf for $13m series A

Industrial internet-of-things technology developer Cloudleaf will use the proceeds from its Mahindra Group-backed series A round for innovation and product commercialisation.

Sep 22, 2017

ThinkCerca writes up series B round

TAL Education and existing investor Follett Corporation were among the participants in a $10.1m round that took the total raised by the critical skills learning platform to $14.8m.

Sep 22, 2017

Vexata defines $54m series A

Intel Capital has participated in an inaugural funding round for Vexata, which has just released its data storage technology platform.

Sep 21, 2017

Luno pockets $9m series B round

The digital wallet operator has raised $9m in a series B round that will help consolidate its product launch in 40 different markets.

Sep 21, 2017

Disarm persuades investors for series A

AbbVie Ventures is among the backers of a $30m series A round for Disarm Therapeutics, a biotechnology spinout from Washington University in St Louis.

Sep 21, 2017
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here